Claire Bombardier

University Health Network

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Mohammad Movahedi

Assistant Professor (Status)

University of Toronto Dalla Lana School of Public Health

CANADA

View details

Claire E. H. Barber

CANADA

View details

Janet Pope

Professor of Medicine, Division Head Rheumatology

University of Western Ontario

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Claire Bombardier

Research Interests

Explore related searches

Contact this professor

Articles (10)

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1

Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry

Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative

Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes

Changes in market share of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for treatment of rheumatoid arthritis: Results from the ontario best-practice research initiative database

Health care costs of rheumatoid arthritis: A longitudinal population study

Interventions for tophi in gout

Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: Results from the Ontario Best Practices Research Initiative (OBRI)

Changes in opioid prescribing behaviors among family physicians who participated in a weekly tele-mentoring program

Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: Results from a real-world rheumatoid arthritis cohort

Collaborators (3)

Mohammad Movahedi

Claire E. H. Barber

Janet Pope

Make your next move.